XBiotech Inc. announced that it plans to expand it's campus headquarters with the construction of a new, research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation and groundwork is expected to begin 1 quarter 2024. The new four-story building, to be located close to the existing 46,000 ft manufacturing and R&D facility, will provide key infrastructure to support commercialization plans for the company's Natrunix rheumatology program.

In keeping with XBiotech's desire to preserve the woodlands nature on the 48 acre campus, a subterranean parking garage is being constructed to minimize footprint and ecological impact of the new structure.